Open innovation networks between academia and industry: an imperative for breakthrough therapies

被引：108

作者：

Melese, Teri ^{[1
]}

Lin, Salima M. ^{[2
]}

Chang, Julia L. ^{[2
]}

Cohen, Neal H. ^{[1
,3
]}

机构：

[1] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA

[2] IBM Corp, Global Business Serv, Armonk, NY 10504 USA

[3] Univ Calif San Francisco, Dept Anesthesia & Perioperat Care, San Francisco, CA USA

来源：

NATURE MEDICINE | 2009年 / 15卷 / 05期

关键词：

CONFLICTS-OF-INTEREST; TECHNOLOGIES; SCIENCE; TIME;

D O I：

10.1038/nm0509-502

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

引用

页码：502 / 507

页数：6

共 25 条

[1] The biomarkers consortium: On the critical path of drug discovery [J].

Altar, C. A. .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 2008, 83 (02) :361-364

[2]

BERNSTEIN K, 2006, BIOCENTURY, V14, pA1

[3] RNAi technologies: a screen whose time has arrived [J].

Blow, Nathan .

NATURE METHODS, 2008, 5 (04) :361-366

[4] Health industry practices that create conflicts of interest - A policy proposal for academic medical centers [J].

Brennan, TA ;

Rothman, DJ ;

Blank, L ;

Blumenthal, D ;

Chimonas, SC ;

Cohen, JJ ;

Goldman, J ;

Kassirer, JP ;

Kimball, H ;

Naughton, J ;

Smelser, N .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2006, 295 (04) :429-433

[5]

Carpenter Siri, 2007, Science, V317, P966, DOI 10.1126/science.317.5840.966

[6]

Chesbrough H., 2003, OPEN INNOVATION

[7]

Chesbrough H., 2006, OPEN BUSINESS MODELS

[8] Open innovation and strategy [J].

Chesbrough, Henry W. ;

Appleyard, Melissa M. .

CALIFORNIA MANAGEMENT REVIEW, 2007, 50 (01) :57-+

[9] Integrating molecular medicine into the US health-care system: Opportunities, barriers, and policy challenges [J].

Deverka, P. A. ;

Doksum, T. ;

Carlson, R. J. .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 2007, 82 (04) :427-434

[10]

Gordon M., 2007, POINT DEAL NEGOTIATE

← 1 2 3 →